Subcutaneous Low Doses of Interleukin-2 and Recombinant Interferon Alpha with Carboplatin and Vinblastine in Patients with Advanced Melanoma1

Publisher： Karger

E-ISSN： 1423-0232|55|1|48-52

ISSN： 0030-2414

Source： Oncology, Vol.55, Iss.1, 1997-12, pp. : 48-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Outpatient Phase II Study of Subcutaneous Interleukin-2 and Interferon-Alpha-2b in Combination with Intravenous Vinblastine in Metastatic Renal Cell Cancer

By  

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 10-15

Karger

Access to resources Recommend Favorite

Clinical Pilot Study of Intrahepatic Arterial Chemotherapy with Methotrexate, 5-Fluorouracil, Cisplatin and Subcutaneous Interferon-Alpha-2b for Patients with Locally Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 39-47

Karger

Access to resources Recommend Favorite

Effects of Adjuvant Interferon‐alpha Low‐dose Therapy in Melanoma Patients on Serum Inhibin B

By  

THE JOURNAL OF DERMATOLOGY, Vol. 27, Iss. 10, 2000-10 ,pp. : 639-642

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Response to Daily Low-Dose Subcutaneous Interferon-α2b in a Patient with Pretreated Metastatic Uveal Melanoma in the Liver and Lung

By  

Case Reports in Oncology, Vol. 1, Iss. 1, 2008-11 ,pp. : 5-10

Karger

Access to resources Recommend Favorite

Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal Cell Cancer Patients

By  

Urologia Internationalis, Vol. 64, Iss. 1, 2000-04 ,pp. : 3-8

Karger

Access to resources Recommend Favorite